天然产物研究与开发 ›› 2026, Vol. 38 ›› Issue (8): 1679-1686.doi: 10.16333/j.1001-6880.2026.8.006 cstr: 32307.14.1001-6880.2026.8.006

• 研究论文 • 上一篇    下一篇

二氢杨梅素抑制斑马鱼尾静脉血栓形成的作用与机制

资石祥†,陈彩艳†,李  文,陈云志,陈  帅*   

  1. 贵州中医药大学基础医学院,贵阳 550025
  • 出版日期:2026-08-27 发布日期:2026-08-26
  • 基金资助:
    国家自然科学基金(82360860);贵州省自然科学基金(黔科合基础-ZK[2023]一般405);贵州省卫生健康委科学技术基金(gzwkj2022-481);国家级大学生创新创业训练计划(202310662135)

Inhibitory effects and mechanisms of dihydromyricetin against caudal venous thrombosis in zebrafish

ZI Shi-xiang†,CHEN Cai-yan†,LI Wen,CHEN Yun-zhi,CHEN Shuai*   

  1. School of Basic Medicine,Guizhou University of Traditional Chinese Medicine,Guiyang 550025,China
  • Online:2026-08-27 Published:2026-08-26

摘要:

研究二氢杨梅素(dihydromyricetin,DHM)抗斑马鱼静脉血栓的作用和机制。选取受精后3天的斑马鱼于6孔板中,随机分为空白对照组、模型组、DHM低、中、高剂量给药组(50、100、200 mg/mL)、阿司匹林组(25 mg/mL)。用DHM或阿司匹林饲养斑马鱼6 h后,除空白对照组外,其余各组均给予30 mg/mL花生四烯酸1 h建立斑马鱼尾静脉血栓模型。通过对斑马鱼尾静脉及心脏红细胞染色评估DHM抗静脉血栓作用,活体荧光成像观察中性粒细胞活化与募集,RT-qPCR检测髓过氧化物酶(myeloperoxidase,MPO)、肿瘤坏死因子-α(tumor necrosis factor-alpha,TNF-α)及白细胞介素-6(interleukin-6,IL-6)mRNA表达,荧光探针法测定活性氧(reactive oxygen species,ROS)水平,显微镜观察肠道出血情况评估安全性,分子对接验证与关键靶点的结合活性。结果显示,与模型组相比,DHM能显著减少斑马鱼尾静脉血栓形成(P<0.01),增加心脏红细胞染色面积(P<0.01),减少中性粒细胞荧光强度(P<0.01),抑制MPOP<0.001)、TNF-αP<0.001)和IL-6P<0.01)mRNA的表达,抑制ROS(P<0.001)的产生,且DHM组不会引起斑马鱼出血反应。分子对接结果显示DHM与TNF-α、IL-6、MPO及ROS相关蛋白还原型烟酰胺腺嘌呤二核苷酸磷酸氧化酶2(nicotinamide adenine dinucleotide phosphate oxidase 2,NOX2)均有较好的亲和力。以上结果表明,DHM可能通过抑制斑马鱼血栓形成过程中TNF-α/IL-6-ROS-MPO信号轴减少斑马鱼尾静脉血栓的形成,且不引起出血反应。

关键词: 静脉血栓栓塞症, 斑马鱼, 二氢杨梅素, 中性粒细胞胞外诱捕网, 髓过氧化物酶, 炎症反应

Abstract:

This study aims to elucidate the effect and mechanism of dihydromyricetin (DHM) against venous thrombosis in zebrafish. Zebrafish at 3 days post-fertilization were randomly divided into six groups: a blank control, model, DHM low, medium, and high dose groups (50, 100, and 200 μg/mL), and an aspirin group (25 μg/mL). After six hours of treatment with DHM or aspirin, all groups except the blank control were exposed to 30 mg/mL arachidonic acid for 1 hour to induce caudal vein thrombosis. The caudal vein and cardiac erythrocytes of zebrafish were stained to evaluate the antivenous thrombosis effect of dihydromyricetin (DHM), live fluorescence imaging was employed to observe neutrophil activation and recruitment, RT-qPCR was performed to determine the mRNA expression levels of myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6), reactive oxygen species (ROS) levels were measured using a fluorescent probe assay, intestinal hemorrhage was examined under a microscope to assess the safety of DHM, molecular docking was conducted to verify its binding activity with key targets. Results showed that compared to the model group, DHM significantly reduced thrombus formation in the caudal vein (P < 0.01), increased cardiac red blood cell staining area (P < 0.01), decreased neutrophil fluorescence intensity (P < 0.01), and suppressed mRNA expression of MPO (P < 0.001), TNF-α (P < 0.001), and IL-6 (P < 0.01). DHM also markedly inhibited ROS generation (P < 0.001). DHM did not cause intestinal bleeding at any tested concentrations. Molecular docking indicated that DHM exhibited favorable binding affinities with MPO, TNF-α, IL-6, and nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2). These findings suggest that DHM may reduce caudal vein thrombosis in zebrafish by inhibiting the TNF-α/IL-6–ROS–MPO signaling axis, without inducing hemorrhagic effects.

Key words: venous thromboembolism, Zebrafish; Dihydromyricetin, neutrophil extracellular traps, myeloperoxidase, inflammation

中图分类号:  R285